Cancer: The big questions to address in coming years

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 4, 2011, Pages 571-573

  Perera, Frederica P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; CARCINOGEN; NITROSAMINE; PESTICIDE; POLYCYCLIC AROMATIC HYDROCARBON; TOBACCO SMOKE; TUMOR MARKER;

ADULT CANCER; AIR POLLUTION; AUTOMATION; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CHILDHOOD CANCER; CHROMOSOME ABERRATION; DIET; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMICS; GENOTOXICITY; HIGH RISK POPULATION; HIGH THROUGHPUT SCREENING; HUMAN; LIFESTYLE; MOLECULAR EPIDEMIOLOGY; NEOPLASM; NOTE; OCCUPATION; PLACENTAL TRANSFER; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEOMICS; RADIATION; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

HUMANS; MOLECULAR EPIDEMIOLOGY; NEOPLASMS;

EID: 79955751137     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0184     Document Type: Note

References (29)

1. Perera FP, Weinstein IB. Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J Chron Dis 1982;35:58l-600.
2. Harris CC, Weston A, Willey J, Trivers G, Mann D. Biochemical and molecular epidemiology of human cancer: Indicators of carcinogen exposure, DNA damage and genetic predisposition. Environ Health Perspect 1987;75:109-19. (Pubitemid 18061031)
3. Willett WC. Balancing life-style and genomics research for disease prevention. Science 2002;296:695-8. (Pubitemid 34441988)
4. Muir CS. Epidemiology of cancer in ethnic groups. Br J Cancer Suppl 1996;29:S12-6.
5. Sasco AJ. Breast cancer and the environment. Horm Res 2003;60Suppl 3:50. (Pubitemid 37548203)
6. Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005;14:1847-50.
7. Tang D, Phillips DH, Stampfer M, Mooney LA, Hsu Y, Cho S, et al. Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Can Res 2001;61:6708-12. (Pubitemid 32896491)
8. Veglia F, Matullo G, Vineis P. Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2003;12:157-60. (Pubitemid 36194006)
9. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, et al. Promoter hypermethylation ofmultiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006;66:3338-44.
10. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992;339:943-46.
11. Wu HC, Wang Q, Yang HI, Ahsan H, Tsai WY, Wang LY, et al. Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev 2009;18:846-53.
12. Smith M, Zhang L. Biomarkers of leukemia risk: benzene as a model. Environ Health Perspect 1998;106:937-46. (Pubitemid 28419776)
13. Vineis P, Malats N, Porta M, Real FX. Human cancer, carcinogenic exposures and mutation spectra. Mutat Res 1999;436:185-94. (Pubitemid 129750348)
14. Alexandrov K, Cascorbi I, Rojas M, Bouvier G, Kriek E, Bartsch H. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis 2002;23:1969-77. (Pubitemid 36104950)
15. Yu MW, Chiu YH, Chiang YC, Chen CH, Lee TH, Santella RM, et al. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol 1999;149:621-9. (Pubitemid 29162711)
16. Hecht SS, Carmella SG, Akerkar S, Richie JP Jr. 4-(Methylnitrosamino)-1- (3,pyridyl)-1-butanol (NNAL) and its glucuronide, metabolites of a tobacco-specific lung carcinogen, in the urine of black and white smokers. Proc Am Assoc Cancer Res 1994;35:286.
17. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994;54:5801-3. (Pubitemid 24375208)
18. Penney KL, Schumacher FR, Li H, Kraft P, Morris JS, Kurth T, Mucci LA, Hunter DJ, Kantoff PW, Stampfer MJand others. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res 2010;3:604-10.
19. Perera FP. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J Natl Cancer Inst 1996;88:496-509. (Pubitemid 26118720)
20. Birnbaum LS, Fenton SE. Cancer and developmental exposure to endocrine disruptors. Environ Health Perspect 2003;111:389-94. (Pubitemid 36546511)
21. Goldman LR. Children-unique and vulnerable. Environmental risks facing children and recommendations for response. Environ Health Perspect 1995;103:13-8.
22. Buffler PA, Kwan ML, Reynolds P, Urayama KY. Environmental and genetic risk factors for childhood leukemia: appraising the evidence. Cancer Invest 2005;23:60-75. (Pubitemid 40344201)
23. Bocskay KA, Tang D, Orjuela MA, Xinhua L, Warburton DP, Perera FP. Chromosomal aberrations in cord blood are associated with prenatal exposure to carcinogenic polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomarker Prev 2005;14:506-11. (Pubitemid 40270118)
24. Neri M, Ugolini D, Bonassi S, Fucic A, Holland N, Knudsen LE, et al. Children's exposure to environmental pollutants and biomarkers of genetic damage II. Results of a comprehensive literature search and meta-analysis. Mutat Res 2006;612:14-39.
25. Pluth JM, Ramsey MJ, Tucker JD. Role of maternal exposures and newborn genotypes on newborn chromosome aberration frequencies. Mutat Res 2000;465:101-11. (Pubitemid 30119924)
26. Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, Greaves RF. Backtracking leukemia to birth: identification of clonotypic gene fusion fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A 1997;94:13950-4. (Pubitemid 28009690)
27. Wiemels JL, Greaves M. Structure and possible mechanisms of TELAML1 gene fusions in childhood acute lymphoblastic leukemia. Cancer Res 1999;59:4075-82. (Pubitemid 29393580)
28. Lund E, Dumeaux V. Systems epidemiology in cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2954-7.
29. Vineis P, Perera F. Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev 2007;16:1954-65. (Pubitemid 47621168)